STOCK TITAN

American Well Corp Stock Price, News & Analysis

AMWL NYSE

Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.

American Well Corp (AMWL) is a leading telehealth platform enabling digital care solutions across healthcare ecosystems. This page serves as the definitive source for verified news and official announcements from the company, providing stakeholders with timely insights into strategic developments.

Access comprehensive updates including earnings reports, technology innovations, partnership announcements, and regulatory milestones. Investors and industry observers can track AMWL's progress in advancing hybrid care models and expanding its digital health infrastructure.

All content is curated to ensure relevance to AMWL's operations in virtual care delivery, platform enhancements, and collaborations with healthcare providers. Bookmark this page for efficient monitoring of the company's evolving role in shaping accessible, technology-driven healthcare solutions.

Rhea-AI Summary

Amwell (NYSE: AMWL) has announced the launch of Amwell Psychiatric Care, a new telepsychiatry solution aimed at hospitals and health systems to address the escalating demand for behavioral healthcare in the U.S. This service offers 24/7 access to board-certified psychiatrists and seeks to improve patient throughput in emergency departments. Asana Integrated Medical Group, part of Amwell since 2019, has received The Joint Commission's Gold Seal for Behavioral Healthcare Accreditation, reinforcing Amwell's commitment to quality care in the mental health sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL) announced new leadership appointments, with Egbert van Acht as Executive Vice Chairman and Frank McGillin as CEO. This joint venture with Cleveland Clinic aims to enhance digital health services, especially in telemedicine, which has surged during the COVID-19 pandemic. The company focuses on offering high-acuity care via its MyConsult platform, supporting over 2,000 conditions. Both leaders bring extensive experience from global organizations, highlighting the company's strategy to leverage Cleveland Clinic's expertise and Amwell's technology for improved patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.36%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL) announced the participation of Ido Schoenberg and Keith Anderson in the 32nd Annual Piper Sandler Virtual Healthcare Conference from December 1-3, 2020. They will engage in a fireside chat on December 3 at 1:00 p.m. EDT. A live audio webcast, along with a replay, will be accessible on Amwell's investor relations website for approximately 90 days following the presentation.

Amwell is a leading telehealth platform, empowering over 2,000 hospitals and 55 health plan partners. The company connects providers and patients, delivering affordable, high-quality healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
conferences
Rhea-AI Summary

Amwell, a telehealth leader (NYSE: AMWL), announced its Q3 2020 financial results, showing significant growth amid increased telehealth demand. Total active providers surged to ~62,000, with total visits reaching ~1.41 million, up from 255,000 YOY. Total revenue was $62.6 million, compared to $34.7 million last year, driven by strong subscription and visit revenues. However, gross margin declined to 32.7% from 45.1%, and the net loss expanded to $(64.6) million from $(24.1) million. The company expects full-year revenue between $235 and $239 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.04%
Tags
-
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced new telehealth products including Amwell Now, Touchpoint Tablet software, and the C500 telemedicine cart to enhance virtual care delivery amid the ongoing COVID-19 pandemic. These offerings aim to simplify and integrate telehealth services for healthcare providers and patients, improving accessibility and efficiency. Amwell Now provides quick video visit capabilities, while the Touchpoint software enables bedside video connectivity. The C500 cart features advanced technology for remote exams, supporting diverse healthcare specialties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.52%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL) has achieved full URAC Accreditation in Telemedicine, reinforcing its commitment to quality virtual care during the ongoing pandemic. This independent accreditation, awarded for the second time, showcases Amwell's adherence to URAC's rigorous standards for safety, privacy, and quality in healthcare delivery. Ido Schoenberg, Co-CEO of Amwell, emphasized that this accreditation ensures their clients and patients can trust in their telehealth services. URAC's President highlighted the significance of this achievement in promoting value-based care access amidst rapid changes in the telehealth industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13%
Tags
none
Rhea-AI Summary

Amwell (NYSE: AMWL) will report its Q3 operating results on November 12, 2020, following which a live conference call will take place at 5:00 p.m. ET. Investors can access the audio webcast through investors.amwell.com. Amwell is a leading telehealth provider, offering services to over 2,000 hospitals and 55 health plans, covering more than 80 million lives. The company believes in transforming healthcare through digital care delivery and provides comprehensive telehealth solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.63%
Tags
conferences earnings
-
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced the appointment of Ms. Deborah C. Jackson to its Board of Directors, effective immediately. With over 30 years of leadership experience, Jackson currently serves as President of Cambridge College and previously was CEO of the American Red Cross of Eastern Massachusetts. Ido Schoenberg, Co-CEO, expressed confidence in Jackson's ability to offer valuable insights as the company transitions into a new growth phase in digital health. Amwell, a leader in telehealth, connects providers and patients while aiming to expand access to affordable healthcare solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.9%
Tags
management
-
Rhea-AI Summary

Amwell (NYSE: AMWL) released its annual Physician and Consumer Survey on October 6, 2020, revealing a substantial increase in telehealth usage. In 2020, 22% of consumers and 80% of physicians reported having virtual visits, a rise from 8% and 22% in 2019. Key findings show a shift toward scheduled visits and a significant increase in virtual specialty care. However, challenges persist, with 72% of physicians citing technology issues as a barrier. The company emphasizes the importance of telehealth in future healthcare, integrating both virtual and physical care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.67%
Tags
none
Rhea-AI Summary

Amwell (NYSE: AMWL) has been recognized as the top telehealth provider for patient satisfaction in the J.D. Power 2020 U.S. Telehealth Satisfaction Study, scoring 885 compared to the industry average of 860. The study surveyed 4,302 patients and assessed factors such as customer service (42%), consultation (28%), enrollment (19%), and billing/payment (11%). This recognition underlines Amwell's commitment to enhancing virtual care experiences, especially in response to increased demand due to the COVID-19 pandemic. The company aims to provide seamless integration of telehealth with traditional care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.35%
Tags
none

FAQ

What is the current stock price of American Well (AMWL)?

The current stock price of American Well (AMWL) is $5.68 as of October 16, 2025.

What is the market cap of American Well (AMWL)?

The market cap of American Well (AMWL) is approximately 95.9M.
American Well Corp

NYSE:AMWL

AMWL Rankings

AMWL Stock Data

95.94M
13.17M
5.61%
44.02%
1.05%
Health Information Services
Services-business Services, Nec
Link
United States
Boston